Ferring Controlled Therapeutics is an API and finished-dose manufacturer based in United Kingdom. It appears in 8 regulatory filings across 6 regulators, without an active US DMF or CEP on file. Its filings concentrate with NPRA (MY), MINSA (CR) and JFDA (JO). Its GMP standing is certified by MHRA (UK), ANVISA (Brazil) and NCELS (KZ), among 4 authorities. Its most recent recorded inspection, by US FDA, closed on 30 May 2019 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| East Kilbride, United Arab Emirates | Not on file |
| GLASGOW, United Kingdom | Not on file |
| GLASGOW, United Kingdom | Not on file |
| United Kingdom, United Kingdom | 3002806756 |
| Ambernath, India | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Mesalazine | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| NPRA (MY) | 2 | None |
| MINSA (CR) | 2 | None |
| JFDA (JO) | 1 | None |
| INVIMA (CO) | 1 | None |
| ARCSA (EC) | 1 | None |
| EDE (AE) | 1 | None |
| MHRA (UK) | None | 5 |
| ANVISA (Brazil) | None | 3 |
| NCELS (KZ) | None | 2 |
| EMA | None | 1 |
Choose your molecules and target markets. Ferring Controlled Therapeutics comes back tiered against every other supplier able to file there.
Start for free